Stay updated on AGN-150998 in AMD Clinical Trial
Sign up to get notified when there's something new on the AGN-150998 in AMD Clinical Trial page.

Latest updates to the AGN-150998 in AMD Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page; this appears to be a minor version update.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. The funding-lapse notice and Revision: v3.4.1 text were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedNotice about government funding lapse and NIH operations was added to the page, and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle and updated metadata: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or updated.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. There are no visible changes to the study content, endpoints, or results.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now includes Location sections for Arizona and New South Wales and removes the previous Arizona Locations and New South Wales Locations entries. The page revision is updated to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to AGN-150998 in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGN-150998 in AMD Clinical Trial page.